The Lancet Global Health 2023

3 papers
In 2023, research in *The Lancet Global Health* focused on infectious disease immunology, epidemic preparedness, and health economics. A primary area of investigation involved the safety and immunogenicity of Ebola vaccine regimens in pediatric populations. Specifically, studies evaluated the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo regimen in infants across Guinea and Sierra Leone. Prolific contributors to this research included A. Bangura, A. Kamara, and Abdoul Habib Béavogui. The year’s publications also addressed strategic responses to respiratory viruses through mathematical modeling, specifically examining proactive and reactive vaccination strategies for health-care workers against MERS-CoV. Additionally, the research extended to non-communicable disease management, featuring a cost-effectiveness analysis of population-based screening for blindness-causing eye diseases in China. These works highlight a trend toward using clinical trial data and economic evaluation to refine public health interventions and resource allocation in diverse geographic contexts.

Top Research Directions

The 4 research directions with The Lancet Global Health 2023 papers, ranked by paper count, next to 2022. Share is the fraction of the edition’s papers in the direction.

#Direction20232022Share 2023Share 20222022 rank
1Comparative Intervention Designs for Causal Inference1033.3%0.0%—
2Heterologous Prime-Boost Vaccination1033.3%0.0%—
3Identifying and Validating Immune Correlates of Protection1033.3%0.0%—
4Mitigating Spatial Aggregation Bias in Public Health1033.3%0.0%—

Download all directions as CSV

Institutions

Institutions credited by The Lancet Global Health 2023 papers: a paper credits every institution named in its affiliations, once. 5 institutions share 1 credited papers.

#InstitutionPapersShare20222022 rank
100394zv26 1100.0%0—
202yw1f353 1100.0%0—
3Centre Hospitalier Universitaire de Bordeaux 1100.0%0—
4Inserm 1100.0%0—
5Université de Bordeaux 1100.0%0—

Download all institutions as CSV

About this data

Papers. The Lancet Global Health 2023 lists 3 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2022 use shares, since the edition went from 4 to 3 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 3 papers (33.3%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “The Lancet Global Health 2023”, https://lacuna.tiptreesystems.com/venue/the-lancet-global-health/2023.

Top Authors

AuthorPapers
Huiqi Li1
Rodolphe Thiébaut1
Samir Bhatt1

Papers

Title
Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis
Impact of proactive and reactive vaccination strategies for health-care workers against MERS-CoV: a mathematical modelling study
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Le